Sellwin Traders Allots 10.15M Shares via Warrant Conversion

Sellwin Traders' board approved conversion of 10,154,056 warrants into equity shares at ₹8.40 per share on 2nd May 2026.
The conversion increases issued share capital to ₹49.00 crore comprising 24,501,556 equity shares of ₹2 each.
Allotment was made to 46 allottees including Mideast Healthcare (1.63% stake) and Rupaben Raval (0.50% stake).
Disclosure made under SEBI LODR Regulation 30 regarding preferential allotment outcome and post-issue shareholding pattern.